Home › Funds › HARRIS ASSOCIATES L P › ELV

HARRIS ASSOCIATES L P position in ELV

ELEVANCE HEALTH INC FORMERLY · Health Care

HARRIS ASSOCIATES L P reported holding 4,924,511 shares of ELV (ELEVANCE HEALTH INC FORMERLY) in its Q2 2026 13F filing — a position valued at US$1.90B, representing 2.54% of its reported portfolio and ranking #11 among its reported holdings. HARRIS ASSOCIATES L P has disclosed ELV holdings in 7 of the last 7 reported quarters, going back to Q4 2024.

Latest position (Q2 2026)4.92M sh
Reported value held$1.90B
Portfolio Weight2.54%
First reportedQ4 2024
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How HARRIS ASSOCIATES L P's ELV position evolved

HARRIS ASSOCIATES L P first disclosed a stake in ELV in Q4 2024 at 1,821,284 shares (US$671.9M). The position peaked in Q2 2026 at 4,924,511 shares, worth US$1.90B. Across 7 filings, HARRIS ASSOCIATES L P increased the stake 4 time(s), trimmed it 1 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 4,924,511 shares valued at US$1.90B — an increase of 4,584,511 shares quarter over quarter.. Notable position changes include a 50% increase in Q4 2025 (shares fell 16% over the following quarter), a 93% trim in Q1 2026 (shares rose 33% over the following quarter), a 1348% increase in Q2 2026 (shares were roughly flat over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2024 1.82M $671.87M New
Q1 2025 2.28M $991.78M Add
Q2 2025 2.29M $889.77M Hold
Q3 2025 3.19M $1.03B Add
Q4 2025 4.79M $1.68B Add
Q1 2026 340.00K $99.53M Reduce
Q2 2026 4.92M $1.90B Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ELV and 13F data

ELV (ELEVANCE HEALTH INC FORMERLY) is a Health Care company. 22 other funds we track also report a position in ELV — the largest reported positions include Wellington Management Group (US$3.56B), WELLINGTON MANAGEMENT GROUP LLP (US$3.56B), Sanders Capital, LLC (US$2.25B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ELV

All ELV fund holders →

FAQ

How long has HARRIS ASSOCIATES L P held ELV?

HARRIS ASSOCIATES L P has disclosed ELV holdings in 7 of the last 7 reported quarters, going back to Q4 2024.

What is HARRIS ASSOCIATES L P's current position in ELV?

As of Q2 2026, HARRIS ASSOCIATES L P holds 4.92M shares of ELV (ELEVANCE HEALTH INC FORMERLY), valued at $1.90B, representing 2.54% of its reported portfolio and ranking #11.

Has HARRIS ASSOCIATES L P been buying or selling ELV?

In the latest 13F filing (Q2 2026), HARRIS ASSOCIATES L P increased its position in ELV. The position peaked in Q2 2026 at 4.92M shares.

Which other funds hold ELV?

Other major institutional holders of ELV include Wellington Management Group, WELLINGTON MANAGEMENT GROUP LLP, Sanders Capital, LLC, among 22 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.